Opexa Therapeutics (OPXA) Reports Year End 2013 Financial Results And Provides Corporate Update
2/28/2014 7:19:22 AM
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing a novel T-cell immunotherapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2013, and provided an overview of recent corporate developments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by